Trial intelligence / Profile preview

Pumpkin Cream vs Estrogen Vaginal Cream for Vaginal Atrophy in Postmenopausal Women

IRCT20240104060610N1Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of DehydraTECH-estrogen in vaginal atrophy and genitourinary syndrome of menopause (GSM) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Improvement in vaginal atrophy symptoms. Started Apr 2024; status: completed.

02

Drugs

DehydraTECH-estrogen
03

Conditions

vaginal atrophygenitourinary syndrome of menopause (GSM)

Beyond the preview

Go deeper on IRCT20240104060610N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240104060610N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call